CI vs ENTA · P/E 2.4, rev $274.90B vs rev $65.3M
Cigna Corp (CI) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the CI and ENTA stock pages for the full models.
Not investment advice.